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The same equation was applied to determine albumin concen­
tration in BAL. Albumin was used as a marker of inflamma­
tion.
Dapsone concentration in plasma and BAL fluid was de­
termined with a validated high performance liquid chroma­
tography assay.6 The standard curve in plasma was linear in 
the range of 12.5 to 3000 ng/ml. The sensitivity of the assay 
for determination of dapsone in BAL was enhanced by 10-fold 
concentration of the BAL samples and standards in saline 
solution. The standard curve was linear in the range of 2.5 to 
300 ng/ml of unconcentrated standards. Interday and intra­
day variability determined at each point of both plasma and 
BAL standard curves was <10%, The lower limit of quanti­
tation was 12.5 ng/ml in plasma and 2.5 ng/ml in BAL.
Results. BAL for Patient 1 was negative for P. carinii and 
acid-fast bacteria. The presence of fungal spores without 
mycelial forms was reported. Also rare colonies of viridans 
streptococci were cultured, The number of neutrophils, mac­
rophages and lymphocytes in BAL sample was within normal
range.
The specimen from Patient 2 was negative for P. carinii, 
fungi and acid-fast bacteria and positive for Streptococcus 
pneumoniae. The BAL sample was purulent with a high count 
of neutrophil cells.
The concentrations of dapsone in plasma and ELF are 
shown in Table 1. The concentration of albumin in ELF was 
2% of the serum concentration in Patient 1 and 12% in 
Patient 2.
Discussion. Our data suggest that dapsone penetrates 
well into ELF. This observation was expected because dap­
sone is highly lipid-soluble with a small molecular weight. 
The difference in plasma concentrations reflects the high 
interpatient variability of dapsone pharmacokinetics re­
ported in both adult and pediatric HIV-infected patients.6,9 
The fact that Patient 2 had signs of pulmonary inflammation 
and a higher penetration ratio may suggest that dapsone 
penetration into ELF is greater in the presence of inflamma­
tion. This may be clinically relevant because chronic inflam­
mation in patients with a history of multiple pneumonias is a 
common finding in HIV-infected children. However, our ob­
servation regarding the effect of inflammation on dapsone 
penetration into ELF should be confirmed by further studies.
We studied the concentrations of dapsone at 24 h after 
administration; therefore we do not know the concentrations 
in the interval between doses. Dapsone half-life in the plasma 
of HIV-infected children has been reported to range from 18.2 
to 35 h.6 If no degradation of dapsone occurs in ELF, the 
half-life of dapsone in ELF should be comparable with or 
longer than the half-life in plasma. As a result the concentra­
tions in ELF should be higher than the MIC of 0.1 mg/l10 for 
most of the dosing interval when 2 mg/kg are administered 
three times weekly. To interpret our data correctly in terms of 
predicting clinical outcome, the pharmacodynamic aspects of 
dapsone against P. carinii should be elucidated. Such infor­
mation is crucial to the design of a dosage regimen targeted to 
optimize peak and trough concentrations in relation to the 
MIC of P, carinii.
In conclusion additional studies are required to provide a 
sound pharmacokinetic basis for determining the optimal
TABLE 1. Steady state concentrations of dapsone in the 
alveolar ELF and plasma of pediatric HIV-infected patients
Patient Time (h) ELF (mg/l) Plasma (mg/l) ELF:Plasma Ratio
1 24 1.11 1.02 1.09
2 24 1.64 0.48 3,41
dapsone regimen for P. carinii pneumonia prophylaxis in 
HIV-infected children.
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SEVERE NEONATAL ECHOVIRUS 20 INFECTION 
CHARACTERIZED BY HEPATIC FAILURE
Enteroviruses, small, single stranded RNA viruses, are a 
common cause of neonatal infection, especially in summer 
and fall.1-4 The 66 known serotypes are grouped into 4 
classes: polio viruses 1 to 3; Coxsackieviruses A 1 to 22 and 24; 
Coxsackieviruses B1 to B6 and echo viruses 1 to 7, 9,11 to 27
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nd 29 to 33. The more recently discovered serotypes are simply 
designated enteroviruses and numbered 68 to 71. More than 
50% of enterovirus infections are caused by echo viruses.
Clinical presentations vary from benign nonspecific febrile 
illness to severe disseminated life-threatening disease. Al­
though nearly all 30 echo viruses may cause neonatal disease, 
7 serotypes have been reported to cause severe disease. The 
dominant serotype responsible for severe neonatal disease is 
echovirus l l . 5 The most common clinical presentation of 
serious echovirus disease in neonates is sepsis-like illness 
characterized by fever at onset. The differentiation from 
bacterial sepsis is a diagnostic problem.2”4 Previous reviews 
have not identified echovirus 20 as a cause of severe neonatal 
disease. Recently four cases of severe neonatal disease caused 
by echovirus 20 occurred in the Netherlands within a period 
of 8 weeks. Liver failure was a dominant feature in 3 of 4 
patients and the disease was fatal in one of them*
Case 1. On August 28, 1995, a 2640-g birth weight, 
37V2-week gestation female infant was born to a multigravida 
by cesarean section because of signs of infection of the mother 
(temperature of 39°C and abdominal pain). The Apgar scores 
were 8 and 9 at 1 and 5 min, respectively, and the examina­
tion was normal. On the fifth day of life the infant developed 
fever (temperature 38.8°C) but did not look ill. The laboratory 
results were normal. A blood sample was obtained for culture 
and antibiotics were given. Twenty-four hours later the 
patient became lethargic and developed feeding problems, 
with a distended, painful abdomen. The white blood cell 
{WBC) count decreased from 14 X 109/1 to 6.3 X 109/1 and the 
platelet count decreased from 378 X 109/1 to 20 X 109/1, 
whereas C-reactive protein was normal. The liver function 
tests showed elevated levels of lactate dehydrogenase (LDH) 
at 7400 units/1 (range, 26 to 334 units/1), serum aspartate 
aminotransferase (AST) at 944 units/1 (range, 7 to 47 units A) 
and serum alanine aminotransferase at 145 units/1 (range, 3 
to 47 units/1). The radiograph of the abdomen was normal. 
Ultrasound examination of the abdomen revealed ascites. 
Viral cultures of nasopharynx, stool and serologic tests were 
performed. There was laboratory evidence of disseminated 
intravascular coagulopathy (DIC). The patient was trans­
ferred to the neonatal intensive care unit (NICU) of the 
Academic Hospital Nijmegen on the eighth day of life. The 
physical examination on admission was normal except for 
some cutaneous hematomas. Cerebrospinal fluid (CSF) anal­
ysis showed no abnormalities. Viral cultures of CSF and blood 
were performed. Treatment consisted of antibiotics, acyclovir 
and fresh frozen plasma, platelet and red blood cell transfu­
sions. Within the 3 following days the signs of DIC disap­
peared. All bacterial cultures were sterile. Viral culture of the 
stool and nasopharynx obtained on the eighth day of life and 
the viral culture of blood obtained on the ninth day of life 
yielded enterovirus later typed as echovirus 20. The viral 
culture of CSF was negative. Cultures taken from the mother 
were also negative. The serologic tests of the patient revealed 
a significant rise in titer of neutralizing antibodies to the 
patient’s own virus isolate from 1:8 on Day 8 to 1:128 on Day
13. On the 23rd day of life the patient was discharged in good 
clinical condition.
Case 2. On October 10, 1995, a 3225-g birth weight, 
39-week gestation male infant was born to a healthy multi­
gravida by elective cesarean section. Apgar scores were 8 and 
9 after 1 and 5 min, respectively, and the examination was 
normal. On the seventh day of life the infant developed fever 
(temperature 38.4°C) and anorexia and became lethargic. No 
focus of infection was detected. The laboratory results showed 
a hemoglobin of 7.8 mmol/1, a WBC count of 4.7 X 109/1 with 
14% band forms, a platelet count of 103 X  109/1 and a
C-reactive protein level of 17 mg/1, CSF analysis was not 
possible because of a traumatic tap. After samples were 
obtained for cultures, antibiotics and acyclovir were given, 
The patient was transferred to the NICU of the University 
Children’s Hospital Utrecht. On admission the infant was 
lethargic, with a distended, painful abdomen without organo­
megaly and required ventilatory support. There were no 
radiographic signs of pneumonia. Laboratory tests revealed a 
WBC count of 2.5 X 109/1 with 18% band forms, a platelet 
count of 42 X 109/1, a slightly increased serum AST of 160 
units/1 and markedly elevated LDH of 1456 units/1, During 
the following hours the infant developed marked edema, 
ascites and pleural and pericardial effusion. Ultrasound ex­
amination of the abdomen revealed ascites and an enlarged 
liver and spleen. There was evidence of DIC ancl progressive 
deterioration of the liver function. The patient became hypo­
tensive, developed seizures and pulmonary function progres­
sively worsened. Despite all therapeutic measures the infant 
died on the fourth day after onset of the first symptoms. All 
bacterial cultures remained sterile. The viral cultures of stool, 
throat and cerebrospinal fluid obtained on the eighth day of 
life yielded enterovirus, later typed as echovirus 20. Postmor­
tem cultures of brain, liver and lungs yielded echovirus 20.
Case 3. On October 19, 1995, a 2720-g birth weight,
36-week gestation female infant was bom to a healthy mul­
tigravida by cesarean section because of abruptio placentae. 
The Apgar scores were 9 and 10 at 1 and 5 min, respectively. 
Because of prematurity the infant was admitted to the neo­
natal nursery. On the fourth day of life the infant developed 
fever (38.2°C), anorexia and lethargy. The initial blood and 
CSF analysis were normal and after samples for culture were 
obtained, antibiotics were given. Within 24 h the patient 
became irritable with a painful, slightly distended abdomen. 
Ultrasound examination of the abdomen revealed minimal 
ascites. Blood analysis showed marked leukopenia with a 
WBC count of 4.6 X 109/1 with 26% band forms, thrombocy­
topenia of 53 X 109/1 and liver dysfunction (LDH, 2125 units/1; 
AST, 139 units/1). The patient was transferred to the NICU of 
the University Children’s Hospital Utrecht.
During the following days hepatosplenomegaly developed 
and the ascites increased. Blood chemistry showed evidence 
of DIC and deterioration of liver function. Treatment con­
sisted of vitamin K, fresh frozen plasma, red blood cell and 
platelet transfusions. Bacterial cultures remained sterile. 
Viral cultures from stool and ascites fluid obtained on the 
seventh day of life yielded enterovirus later typed as echovi­
rus 20, From the second week of illness the infant’s clinical 
condition gradually improved and after 27 days the patient 
was discharged in good clinical condition, but still with signs 
of cholestasis.
Case 4. On October 18, 1995, a 2230-g birth weight,
37-week gestation female infant was born to a healthy mul­
tigravida by vaginal delivery as the second of twins. The 
delivery was induced because of placental insufficiency and 
growth retardation of both fetuses. The Apgar scores were 6 
and 8 at 1 and 5 min, respectively. Because of low birth 
weight the infant was admitted to the neonatal nursery. On 
the fifth day of life the infant developed fever (38.4°C) and 
poor feeding. Physical examination showed prolonged capil­
lary refill, lethargy and a slightly distended abdomen, 
prompting evaluation for possible sepsis. Laboratory results, 
however, were normal. After samples were obtained for bac­
terial culture sepsis therapy was initiated. The clinical con­
dition of the patient improved during the next 24 h, although 
the platelet count dropped to 95 X 109/1. Liver function tests 
were not performed. All bacterial cultures remained sterile. 
Because during the same period another infant (Case 3) in the
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nursery had to be transferred to the NICU with clinical 
manifestations suggesting viral disease, stool was collected 
on the ninth day of life for viral culture, which yielded an 
enterovirus, typed as echo vims 20.
On the 18th day of life the patient was discharged in good 
clinical condition. The twin sister of the patient showed no 
signs of illness and viral cultures were not obtained.
The selected laboratory values and demographic data of the 
four patients are summarized in Tables 1 and 2, respectively.
Epidemiology. The virus diagnostic laboratories that 
participate in the Netherlands Working Group on Clinical 
Virology report on a monthly basis infections that are diag­
nosed throughout the country. This database showed that 
echovirus 20 infections have been relatively rare in the 
Netherlands during the past decades but that their number 
rose significantly in 1994 and 1995. From 1986 to 1993 the 
annual average number of cases of enterovirus infection was 
264 (range, 118 to 509), of which 1% were echovirus 20 
(average annual number, 3; range, 1 to 8). In 1994 the 
percentage of echovirus 20 increased to 10% (28 of 272 
enterovirus cases); in 1995 the contribution of echovirus 20 
increased further to 14% (30 of 207 enterovirus cases). In 
addition we sent a questionnaire to the virus diagnostic 
laboratories, with special emphasis on neonatal infection by 
echovirus 20. Three additional neonatal cases were found, all 
in 1994, 2 of whom had severe illness. One had sepsis-like 
illness and the other meningoencephalitis. The third case had 
gastroenteritis only. These cases were reported by laborato­
ries in Rotterdam and Delft.
Discussion. Sepsis-like illness in neonates can be caused 
by bacteria and some viruses. Severe echovirus infection in 
neonates is such a viral disease characterized by a sepsis-like 
illness at onset. Approximately two-thirds of the patients 
with severe echovirus disease have a systemic manifestation 
and one-third of the patients have meningoencephalitis.5 To 
our knowledge this is the first detailed description of severe 
neonatal infection by echovirus 20. One report, the epidemi­
ologic study of 233 infants younger than 3 months of age and 
admitted with clinical signs of sepsis, described the isolation 
of this serotype four times. The age of the patients, clinical 
course of the illness, laboratory results and outcome were not 
separately described.4 In another report dated from 1960 
echovirus 20 was isolated from asymptomatic infants.6
All four cases described in this report occurred within a 
60-day period in two areas approximately 60 km apart (Utre­
cht and Nijmegen). Three of the infants were admitted within 
a 6-day period from inside the metropolitan area of Utrecht 
(Cases 2, 3 and 4). There were no other relationships among 
the patients. However, Cases 3 and 4 were admitted in the 
same period to the same neonatal unit. In retrospect three 
additional cases were found that occurred in 1994. From the 
epidemiologic data collected by the Netherlands Working 
Group on Clinical Virology, it became evident that there was 
an increased circulation of echovirus 20 in 1994 and 1995. 
Waning of immunity with time passed after a previous 
echovirus 20 epidemic may explain an increased circulation in
1994 and 1995, but not an altered pathogenicity of echovirus 
20 infection in the neonate. Increased virulence of the sero­
type can offer a more likely explanation. This may result in an 
increased awareness of clinically significant infections, occur­
ring also after the neonatal period. Enteroviruses, being RNA 
viruses, have a high mutational frequency that may lead to 
changes in pathogenicity, virulence and antigenicity.7-9 Such 
factors might have been responsible for a newly circulating 
strain of echovirus 20 causing sepsis-like illness in neonates. 
The patients with neonatal echovirus 20 infection described 
here developed a bacterial sepsis-like illness with fever, poor 
feeding and lethargy. The differentiation from bacterial infec­
tion was the main diagnostic problem at onset. Clinical 
chemistry and hematologic findings were not very helpful in 
the differentiation. The temperature was only moderately 
elevated for 1 to 2 days. Signs of liver failure and hepatomeg­
aly developed within the first week of the illness. Severe liver 
failure with DIG characterized three of the four cases. En­
cephalitis and severe capillary leak followed by respiratory 
and circulatory failure were observed in the fulminant course 
of the disease in the case with a fatal outcome,
A nearly identical clinical illness with fulminant liver 
necrosis has been described in neonates with perinatally 
acquired herpes simplex virus, echovirus 11 and Coxsackievi­
rus B infections.5,10,11 Myocarditis, described in other neo­
natal echovirus infections, was not observed in the cases 
reported here.
The previously reported risk factors for severe neonatal 
echovirus disease as prematurity, male sex and maternal dis­
ease, were not evident in our cases.4,12,13 Another important 
risk factor, frequently described in the literature, is cesarean 
section performed because of abdominal illness of the moth­
er.2, 5t 13 Three of our patients had been delivered by cesarean 
section, but only in Case 1 because of maternal disease.
The course of neonatal echovirus 20 infection in our four 
patients was quite variable. Complete uneventful recovery, 
hepatitis followed by chronic liver disease and fulminant 
hepatic necrosis with fatal outcome were observed.
Specific antiviral therapy of neonatal echovirus infection is 
not yet possible. Because the disease is usually self-limiting, 
supportive care is sufficient in most cases).1-3 Treatment with 
intravenous immunoglobulin is another option.2,10,12,14 Pre­
viously one patient with an echovirus 11 infection has been 
described who recovered after transfusions with maternal 
plasma15 and another has been described after liver trans- 
plantation.16
The diagnosis can be made by virus isolation from stool, 
CSF, blood or a nasopharyngeal swab.1”3,12 In some cases the 
diagnosis can be obtained only by PCR and not by culture.17 
Virus isolation took 2 to 7 days in our patients.
The transmission of echoviruses may occur in utero, at 
delivery or postnatally.1,3‘4> 13 The source and the mode of 
transmission of the echovirus 20 infection in our cases re­
mained unclear. Only one of the mothers had symptoms of a 
virus-like illness before delivery. After cesarean section she 
promptly recovered and viral cultures of her throat and stool
TABLE 1. Extremes of laboratory abnormalities in four neonates with echovirus 20 infection
Patient WBC (X 109/1)
Platelets 
(X 10°/l)
AST
(Units/1)
ALT
(Units/1)
LDH
(Units/1) PTT (s) PT (s)
1 6.3 12 2650 1440 13 500 94 62
2 2.5 9 2100 410 10 244 96 180
3 4.6 15 1757 405 9008 72 35
4 6.1 95 NA NA NA NA NA
ALT, alanine aminotransferase; NA, not available; PTC\ partial thromboplastin time; PT, prothrombin time.
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TABLE 2. Demographic data of patients with echovirus 20 infection
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Patient Gestational Age (Weeks)
Birth Weight 
(g) Sex
Age at 
Onset Maternal Disease Outcome
1 37VZ 2640 F 5 Fever, abdominal 
pain
Recovery
2 39 3225 M 7 None Died3 36 2720 F 4 None Cholestasis4 37 2230 F 5 None Recovery
taken on the eighth day after delivery were negative. Viral 
cultures of the parents of other patients were not obtained.
Many outbreaks of echovirus infection in nurseries have 
been described in the literature.5,12,13 Echo viruses may be 
introduced into the nursery by an infected adult, but a 
vertically infected neonate may also be the source of trans­
mission to other infants in the nursery. Good hygienic prac­
tices such as hand washing, mouth care and cohorting of the 
patients may prevent transmission of the virus within the 
neonatal care unit. As far as we could ascertain there was no 
transmission of echovirus 20 from the patients to other 
infants.
In conclusion echovirus 20 may cause a severe neonatal 
disease characterized by a sepsis-like presentation at onset, 
development of severe hepatitis with DIG in the course of illness 
which can lead to a massive hepatic necrosis and death.
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CLOSTRIDIUM TERTIUM MENINGITIS AS THE 
PRESENTING SIGN OF A MENINGOCELE IN A
TWELVE-YEAR-OLD CHILD
Anaerobic bacterial meningitis is a rare entity, usually 
seen as a complication of anaerobic brain abscesses.1 Clos-
